Kaplan-Meier survival curve analysis found that TRPV2 and TRPV4 were significantly associated with HCC patients at stage ii&iii and stage iii&iv, but not at stage all and stage i and ii (Supplementary Fig. S1A). The gene discussed is TRPV4; the disease is hepatocellular carcinoma.